Format

Send to

Choose Destination
See comment in PubMed Commons below
Future Cardiol. 2010 Jan;6(1):67-81. doi: 10.2217/fca.09.57.

Adjuvant therapy for atrial fibrillation.

Author information

1
Lankenau Hospital, MOB East Suite 558, Wynnewood, PA 19096, USA. khaja_s2000@yahoo.com

Abstract

Atrial fibrillation (AF) is the most common heart rhythm disorder, with increasing prevalence in the aging US population and affecting more than 2.3 million people. Current approaches for managing AF are rate- or rhythm-control strategies, both using anti-thrombotic therapy to prevent thromboembolism. While great advances have been made in understanding the pathophysiology of AF, few new strategies have shown promise in prevention or treatment of AF. Recent data suggest that non-antiarrhythmic medication may be useful in modifying the substrate that allows AF precipitation and perpetuation. This article reviews the data on the role of these agents in the prevention and management of AF as an adjunct to standard therapy.

PMID:
20014988
DOI:
10.2217/fca.09.57
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center